Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY14.41 CNY
Change Today +0.61 / 4.42%
Volume 12.8M
As of 3:00 AM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

shandong xinhua pharm co-a (000756) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/15/15 - CNY17.50
52 Week Low
04/29/14 - CNY5.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANDONG XINHUA PHARM CO-A (000756)

Related News

No related news articles were found.

shandong xinhua pharm co-a (000756) Related Businessweek News

No Related Businessweek News Found

shandong xinhua pharm co-a (000756) Details

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, is engaged in the development, manufacture, and sale of bulk pharmaceuticals, preparations, and chemical products. The company operates through Bulk Pharmaceuticals, Preparations, Chemical and other products, and Commerce circulations. It provides antipyretics and analgesics; and drugs for central nervous system, steroids, and cardio cerebrovascular systems, as well as finished dosage forms and pharmaceutical intermediates. The company offers its products in various dosages forms, such as tablets, capsules, injections, and ointments. It also provides contract manufacturing services of APIs and pharmaceutical intermediates, as well as OTC and generic products. In addition, the company is involved in the retail and wholesale of pharmaceutical products, as well as offers building management services. It operates in the People's Republic of China, Europe, the United States, and internationally. The company was founded in 1943 and is based in Zibo City, the People's Republic of China.

6,602 Employees
Last Reported Date: 03/27/15
Founded in 1943

shandong xinhua pharm co-a (000756) Top Compensated Officers

General Manager, Executive Director and Membe...
Total Annual Compensation: CNY490.0K
Executive Chairman, Member of Nomination Comm...
Total Annual Compensation: CNY510.0K
Chairman of the Supervisory Committee
Total Annual Compensation: CNY358.0K
Employee Supervisor
Total Annual Compensation: CNY100.0K
Independent Supervisor
Total Annual Compensation: CNY30.0K
Compensation as of Fiscal Year 2013.

shandong xinhua pharm co-a (000756) Key Developments

Shandong Xinhua Pharmaceutical Company Limited to Build Modern Drug Global Cooperation Center

Shandong Xinhua Pharmaceutical Company Limited declared plans to invest CNY 182 million in building modern medicine international cooperation center including solid preparation workshop and supporting storage and logistics center to fulfill the plan to move and rebuild existing solid preparation workshop for production expansion.

Shandong Xinhua Pharmaceutical Co. Ltd. Provides Group Earnings Guidance for the First Quarter Ending March 31, 2015

Shandong Xinhua Pharmaceutical Co. Ltd. provided group earnings guidance for the first quarter ending March 31, 2015. For the period, the company expects net profit attributable to the shareholders to be in the range of RMB 14,200,000 to RMB 15,800,000, representing an approximate increase of 340%-390% as compared with that during the corresponding period of last year of RMB 3,230,000 and basic earnings per share to be in the range of RMB 0.031 to RMB 0.034 compared to RMB 0.007 a year ago. Based on the information currently available, the expected increase in profit is mainly attributable to the following initiatives adopted by the Company: significant adjustment to the product structure, increase in marketing efforts, expansion of the sales scale of major products, and implementation of in depth research on product technology, leading to reduction of production costs.

Shandong Xinhua Pharmaceutical Co. Ltd. Proposes Final Dividend for the Year Ended 31 December 2014, Payable on or Before 11 August 2015

Shandong Xinhua Pharmaceutical Co. Ltd. proposed the declaration of a final dividend for the year ended 31 December 2014 of RMB 0.02 (equivalent to approximately HKD 0.025) per share in the Company. The Board announced that, if the aforesaid proposed declaration of the final dividend is approved in the annual general meeting of the Company to be held on 24 June 2015, the dividend cum-date and ex-date will be 29 June 2015 and 30 June 2015 respectively. The register of members of the Company for entitlement of dividend will be closed from 3 July 2015 to 9 July 2015 (both days inclusive), during which no H share transfer will be effected. The 2014 final dividend will be paid to the H shareholders (whose names appear on the company's register of holders of H-shares on 9 July 2015) on or before 11 August 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000756:CH CNY14.41 CNY +0.61

000756 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hebei Iron & Steel Co Ltd CNY5.39 CNY +0.32
Nanjing Iron & Steel Co Ltd CNY6.24 CNY +0.19
Wuhan Iron & Steel Co Ltd CNY5.78 CNY +0.26
View Industry Companies

Industry Analysis


Industry Average

Valuation 000756 Industry Range
Price/Earnings 100.0x
Price/Sales 2.0x
Price/Book 3.9x
Price/Cash Flow 85.0x
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG XINHUA PHARM CO-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at